Patents by Inventor Sudarkodi Alagarsamy

Sudarkodi Alagarsamy has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • METHOD OF TREATING PRADER-WILLI SYNDROME
    Publication number: 20240082344
    Abstract: This disclosure relates to a method of treating Prader-Willi Syndrome. The method includes administering to a patient in need thereof an effective amount of a composition containing a selective oxytocin receptor agonist or a pharmaceutically acceptable salt thereof.
    Type: Application
    Filed: November 18, 2022
    Publication date: March 14, 2024
    Applicant: Ferring B.V.
    Inventors: Pascal DANGLAS, Michael REIDY, Paul KORNER, Sudarkodi ALAGARSAMY
  • METHOD OF TREATING PRADER-WILLI SYNDROME
    Publication number: 20200129584
    Abstract: This disclosure relates to a method of treating Prader-Willi Syndrome. The method includes administering to a patient in need thereof an effective amount of a composition containing a selective oxytocin receptor agonist or a pharmaceutically acceptable salt thereof.
    Type: Application
    Filed: October 3, 2019
    Publication date: April 30, 2020
    Applicant: FERRING B.V.
    Inventors: Pascal DANGLAS, Michael REIDY, Paul KORNER, Sudarkodi ALAGARSAMY
  • Method of treating prader-willi syndrome
    Patent number: 10441627
    Abstract: This disclosure relates to a method of treating Prader-Willi Syndrome. The method includes administering to a patient in need thereof an effective amount of a composition containing a selective oxytocin receptor agonist or a pharmaceutically acceptable salt thereof.
    Type: Grant
    Filed: September 14, 2015
    Date of Patent: October 15, 2019
    Assignee: FERRING B.V.
    Inventors: Pascal Danglas, Michael Reidy, Paul Korner, Sudarkodi Alagarsamy
  • Method of Treating Prader-Willi Syndrome
    Publication number: 20170326200
    Abstract: This disclosure relates to a method of treating Prader-Willi Syndrome. The method includes administering to a patient in need thereof an effective amount of a composition containing a selective oxytocin receptor agonist or a pharmaceutically acceptable salt thereof.
    Type: Application
    Filed: September 14, 2015
    Publication date: November 16, 2017
    Inventors: Pascal Danglas, Michael Reidy, Paul Korner, Sudarkodi Alagarsamy
  • Oxytocin receptor agonists
    Patent number: 8748564
    Abstract: The present invention relates to oxytocin receptor agonist compounds, pharmaceutical compositions comprising the same, use of such compounds for the manufacture of a medicament for treatment of inter alia, abdominal pain, irritable bowel syndrome (IBS), autism, erectile dysfunction, female sexual dysfunction, labor induction and maintenance, lactation induction and maintenance, postpartum hemorrhage, Post Traumatic Stress Disorder (PTSD), pain, anxiety and other conditions, as well as to methods for the treatment of such conditions, wherein such compounds are administered.
    Type: Grant
    Filed: September 21, 2010
    Date of Patent: June 10, 2014
    Assignee: Ferring B.V.
    Inventors: Kazimierz Wisniewski, Claudio Daniel Schteingart, Sudarkodi Alagarsamy, Robert Galyean
  • Peptidic GLP-2 agonists
    Patent number: 8580918
    Abstract: Novel GLP-2 analogs with improved pharmacokinetic properties are described as well as their use in the treatment of disease.
    Type: Grant
    Filed: October 21, 2010
    Date of Patent: November 12, 2013
    Assignee: Ferring B.V.
    Inventors: Sudarkodi Alagarsamy, Guangcheng Jiang, Pierre Riviere, Claudio Daniel Schteingart, Javier Sueiras-Diaz, Kazimierz Wisniewski
  • PEPTIDIC GLP-2 AGONISTS
    Publication number: 20120231999
    Abstract: Novel GLP-2 analogs with improved pharmacokinetic properties are described as well as their use in the treatment of disease.
    Type: Application
    Filed: October 21, 2010
    Publication date: September 13, 2012
    Applicant: FERRING B.V.
    Inventors: Sudarkodi Alagarsamy, Guangcheng Jiang, Pierre Riviere, Claudio Daniel Schteingart, Javier Sueiras-Diaz
  • OXYTOCIN RECEPTOR AGONISTS
    Publication number: 20120214733
    Abstract: The present invention relates to oxytocin receptor agonist compounds, pharmaceutical compositions comprising the same, use of such compounds for the manufacture of a medicament for treatment of inter alia, abdominal pain, irritable bowel syndrome (IBS), autism, erectile dysfunction, female sexual dysfunction, labor induction and maintenance, lactation induction and maintenance, postpartum hemorrhage, Post Traumatic Stress Disorder (PTSD), pain, anxiety and other conditions, as well as to methods for the treatment of such conditions, wherein such compounds are administered.
    Type: Application
    Filed: September 21, 2010
    Publication date: August 23, 2012
    Applicant: FERRING INTERNATIONAL CENTER S.A.
    Inventors: Kazimierz Wisniewski, Claudio Daniel Schteingart, Sudarkodi Alagarsamy, Robert Galyean